Unique evolution of angioimmunoblastic T cell lymphoma to Epstein-Barr virus-positive plasma cell myeloma

Ann Hematol. 2020 Dec;99(12):2949-2952. doi: 10.1007/s00277-020-04110-6. Epub 2020 Jun 9.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Brentuximab Vedotin / administration & dosage*
  • Cyclophosphamide / administration & dosage
  • Doxorubicin / administration & dosage
  • Epstein-Barr Virus Infections* / diagnostic imaging
  • Epstein-Barr Virus Infections* / drug therapy
  • Epstein-Barr Virus Infections* / etiology
  • Epstein-Barr Virus Infections* / metabolism
  • Etoposide / administration & dosage
  • Herpesvirus 4, Human / metabolism*
  • Humans
  • Lenalidomide / administration & dosage*
  • Lymphoma, T-Cell* / diagnostic imaging
  • Lymphoma, T-Cell* / drug therapy
  • Lymphoma, T-Cell* / metabolism
  • Male
  • Neoplasms, Second Primary* / diagnostic imaging
  • Neoplasms, Second Primary* / drug therapy
  • Neoplasms, Second Primary* / metabolism
  • Neoplasms, Second Primary* / virology
  • Positron Emission Tomography Computed Tomography*
  • Prednisolone / administration & dosage
  • Vincristine / administration & dosage

Substances

  • Vincristine
  • Etoposide
  • Brentuximab Vedotin
  • Doxorubicin
  • Cyclophosphamide
  • Prednisolone
  • Lenalidomide

Supplementary concepts

  • CHOEP protocol